Skip to main content
. 2020 May 27;64(4):462–478. doi: 10.20945/2359-3997000000258

Table 2. Clinical conditions and groups that benefit from 25-hydroxyvitamin (25[OH]D) concentrations above 30 ng/mL.

Groups Clinical Conditions
Elderly (> 65 years) Pregnant women Osteoporosis (primary or secondary) Fractures due to fragility
  Metabolic bone diseases (osteomalacia, osteogenesis imperfecta, primary hyperparathyroidism) Secondary hyperparathyroidism
  Sarcopenia Recurring falls Chronic renal disease
  Malabsorption syndrome
  Liver failure
  Diabetes mellitus type 1
  Cancer